NCT00323349

Brief Summary

Diabetes mellitus (DM) type 2 is well recognized as a major cause of morbidity and mortality in the United States, as well as a significant contributor to health disparities within the population. Changes in demographic and lifestyle characteristics in the population have led to a progressive increase in the prevalence of both diabetes and impaired glucose tolerance (IGT), a precursor to DM type 2. Although pharmacologic interventions have proven to be successful in blocking the progression from IGT to DM, they have not been as effective as diet and exercise modification. Studies of behavioral interventions in IGT have focused on the outcomes of improved DM risk factors and decreased progression to DM, but have either required extensive interventions that lack applicability to the general population or have utilized more modest interventions with no effect on risk factors. These studies have not included impact evaluations to assess the effect of knowledge of IGT status on motivation to change and perceived risk. This study will assess the impact of knowledge of IGT on the likelihood of altering health-related behaviors, utilizing the Health Belief Model as a conceptual framework. Subjects will be randomized to one of four treatment arms, organized in a factorial design to (1) assess the impact of OGTT testing on motivation to change behaviors and (2) evaluate the efficacy of a novel educational intervention linked to patients' learning styles. This evaluation will determine whether OGTT testing is more beneficial as a cue to action to motivate behavior change than a multifactorial assessment of diabetes risk. Additionally, the improvement in health motivation after an educational intervention is expected to be enhanced when the educational method is tailored to the individual's preferred learning style. This information will provide the foundation for more efficient behavioral interventions for patients at high risk for DM type 2.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
276

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2003

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2003

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2004

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 6, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2006

Completed
Last Updated

June 28, 2007

Status Verified

June 1, 2007

First QC Date

May 6, 2006

Last Update Submit

June 27, 2007

Conditions

Keywords

Glucose Tolerance TestHealth Knowledge, Attitudes, PracticeMotivationCommunicationHealth Behavior

Outcome Measures

Primary Outcomes (2)

  • Scores on perceived risk scale after the intervention

  • Scores on motivation to change behavior scale after the intervention

Secondary Outcomes (2)

  • Scores on scales of perceived benefits of healthy lifestyle choices

  • Scores on scales of perceived barriers to healthy lifestyle choices

Interventions

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Increased risk for diabetes type 2 by one of the following characteristics: (1) BMI\>30, (2) Age\>45, (3) First-degree relative with type 2 diabetes, (4) History of gestational diabetes, (5) Prior elevated fasting glucose in the previous year.

You may not qualify if:

  • History of diabetes (not gestational diabetes)
  • Current laboratory results consistent with diabetes
  • Current pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ghent Family Practice

Norfolk, Virginia, 23507, United States

Location

Portsmouth Family Medicine

Portsmouth, Virginia, 23707, United States

Location

MeSH Terms

Conditions

Prediabetic StateBehaviorCommunicationHealth Behavior

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Laura E Eizember, MD

    Eastern Virginia Medical School

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Intervention Model
FACTORIAL
Sponsor Type
OTHER

Study Record Dates

First Submitted

May 6, 2006

First Posted

May 9, 2006

Study Start

April 1, 2003

Study Completion

December 1, 2004

Last Updated

June 28, 2007

Record last verified: 2007-06

Locations